BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The Collaborative - ECPv6.15.12.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The Collaborative
X-ORIGINAL-URL:https://traininghealthequity.org
X-WR-CALDESC:Events for The Collaborative
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20230323T120000
DTEND;TZID=UTC:20230323T130000
DTSTAMP:20260423T154229
CREATED:20230314T212453Z
LAST-MODIFIED:20230314T212827Z
UID:6278-1679572800-1679576400@traininghealthequity.org
SUMMARY:HIV Learning Network: Updates from CROI 2023
DESCRIPTION:Register \nJoin us for the next HIV Learning Network session on March 23 @ 12:00pm (Pacific) for Updates from CROI 2023\, by Daniel Lee\, MD\, AAHIVS\, HIVLN Clinical Director\, and Clinical Professor of Medicine\, Owen Clinic\, UCSD. \nDescription: The Conference on Retroviruses and Opportunistic Infections (CROI) is a major platform for basic scientists and clinical investigators to present\, discuss\, and critique their research on human retroviruses and associated diseases\, such as HIV and STIs. In this session\, Dr. Daniel Lee\, MD\, AAHIVS\, will distill the most important findings presented at CROI 2023\, and help apply the most relevant data and strategies to future clinical practices for the prevention\, treatment\, and maintenance of HIV and other related infectious diseases. \nLearning Objectives:\nUpon completion of this session\, participants will be able to: \n\nDiscuss the recent data about HIV Pre-Exposure Prophylaxis (PrEP)\nImplement the use of doxycycline for Post-Exposure Prophylaxis (PEP) for preventing sexually transmitted infections (STI) in their clinical practice.\nUtilize the latest data on the use of current and future long-acting injectable agents (Cabotegravir/Rilpivirine\, Lenacapavir\, Islatravir) in people with HIV (PWH) in clinical decision-making\nLearn new strategies in the management of antiretroviral therapy (ART) related weight gain.\n\nPhysicians:\nThis activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of the University of Nevada School of Medicine and the Pacific AIDS Education and Training Center. The University of Nevada\, Reno School of Medicine is accredited by the ACCME to provide continuing medical education to physicians.\nThe University of Nevada\, Reno School of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. \nNurses:\nNurses may receive continuing education credit for this educational activity as the ANCC accepts AMA PRA Category 1 Credits™ through its reciprocity agreement. \nHIV Learning Network offers free CME for participants attending sessions\, pending completion of the post-session evaluation. \nPresented By:\nPacific AETC Regional Office\nContact Email:\nbrian.abascal@ucsf.edu\nContact Number:\n(415) 476-2434\nEvent Type:\nDistance based learning
URL:https://traininghealthequity.org/event/6278/
LOCATION:Zoom
END:VEVENT
END:VCALENDAR